Compare Stocks › DOC vs MS

Healthpeak Properties, Inc. (DOC) vs Morgan Stanley (MS): Which Is the Better Buy in 2026?

As of 2026-11-01, DOC is overvalued at $19, with a DCF intrinsic value of $0 and a margin of safety of -100%. MS is undervalued at $184, with an intrinsic value of $314 and a margin of safety of 41%. Of the two, MS has the wider margin of safety.

DOC
Healthpeak Properties, Inc.
$19.03
VS
MS
Morgan Stanley
$184.30

Rewards

DOC
  • ★Free cash flow has grown at a 11.6% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • ★FCF yield of 12.2% is historically attractive — the business generates significant cash relative to its price.
  • ★Trailing P/E of 54.4x is 22% below the historical average of 69.9x — potentially undervalued relative to its own history.
MS
  • ★Gross margin of 87.3% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★Morgan Stanley scores 80/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • ★Each dollar of retained earnings has created $3.56 of earning power — management is an exceptional capital allocator.

Risks

DOC
  • ⚠Share count has increased by 27% over the past 4 years, diluting existing shareholders.
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠PEG ratio of 4.32 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
MS
  • ⚠Altman Z-Score of 0.29 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • ⚠13 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
DOC
MS
Valuation
$1.65B
Free Cash Flow
N/A
12.19%
FCF Yield
N/A
54.37
Trailing P/E
14.62
135.93
Forward P/E
13.50
Quality & Moat
1.88%
ROIC
3.47%
3.04%
ROE
13.84%
57.65%
Gross Margin
87.31%
4.32
PEG Ratio
1.61
Balance Sheet Safety
0.91
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
5.53
Net Debt / EBITDA
N/A
6.41%
Dividend Yield
2.50%
DOC: 1Ties: 1MS: 7
DOCMS

Historical Fundamentals

Learn more →
DOC

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

MS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
DOC
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-1.68B
Δ Market Cap
$-2.53B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
MS
$6.65
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$20.84B
Δ Market Cap
+$138.59B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
DOC
Insufficient Data
Enter initial FCF to calculate intrinsic value
Current Price: $19.03
Fair Value: $0.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
MS
41.3% Margin of Safety
Price is 41.3% below estimated fair value
Current Price: $184.30
Fair Value: $313.71
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
DOC

What growth rate is the market pricing in at $19?

+46.7%
Market-Implied Owner Earnings Growth
Standard FCF implies +2.3%

The market implies +46.7% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +2.3%, reflecting heavy growth investment.

MS

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
DOC
57/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with margin stability as the key competitive advantage. Improving reinvestment efficiency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
MS
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
DOC
-2.75
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
MS
-2.09
Possible Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
DOC
Insiders 0.3%Institutions 97.8%Retail & Other 1.9%
No. of Institutional Holders1,066
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
MS
Insiders 24.4%Institutions 63.5%Retail & Other 12.1%
No. of Institutional Holders3,458
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
DOC
0
Buys (3M)
0
Buys (12M)
THOMAS JOHN T
Director
$24,730
@ $17.06 · 2025-08-06
BRINKER SCOTT M
Chief Executive Officer
$25,077
@ $16.83 · 2025-08-04
BRINKER SCOTT M
Chief Executive Officer
$49,986
@ $17.06 · 2025-07-31
BRINKER SCOTT M
Chief Executive Officer
$49,990
@ $17.40 · 2025-07-28
THOMPSON TOMMY G
Director
$99,769
@ $17.27 · 2025-05-28
THOMPSON TOMMY G
Director
$98,974
@ $17.36 · 2025-05-09
BRINKER SCOTT M
Chief Executive Officer
$47,822
@ $17.39 · 2025-05-09
LIAS-BOOKER AVA E.
Director
$89,150
@ $17.83 · 2025-04-29
SHELLEY-KESSLER PAMELA J
Director
$49,991
@ $17.61 · 2025-04-28
THOMAS JOHN T
Director
$74,928
@ $17.84 · 2025-04-28
BRINKER SCOTT M
Chief Executive Officer
$200,438
@ $17.68 · 2025-04-28
SANDSTROM KATHERINE M
Director
$199,233
@ $17.65 · 2025-04-28
LEWIS SARA GROOTWASSINK
Director
$105,938
@ $17.66 · 2025-04-28
Open market purchases · includes direct & indirect ownership · excludes option exercises
MS
0
Buys (3M)
0
Buys (12M)
PETERSON DOUGLAS L
Director
$5,630
@ $156.39 · 2025-10-17
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
DOC
0
Sells (3M)
1
Sells (12M)
Total value (12M): $213,740
BOHN SCOTT R
Officer
$213,740
@ $19.45 · 2026-05-12
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
MS
0
Sells (3M)
13
Sells (12M)
Total value (12M): $48.28M
SCHAPIRO MARY L
Director
$212,055
@ $212.06 · 2026-07-28
PIZZI MICHAEL A
Officer
$5.21M
@ $215.55 · 2026-07-17
GROSSMAN ERIC F
Officer
$2.12M
@ $190.75 · 2026-04-20
SIMKOWITZ DANIEL A
President
$2.78M
@ $189.24 · 2026-04-17
CRAWLEY MANDELL L.
Officer
$3.04M
@ $188.22 · 2026-04-16
SAPERSTEIN ANDREW MICHAEL
President
$9.74M
@ $188.59 · 2026-04-16
SIMKOWITZ DANIEL A
President
$6.02M
@ $182.61 · 2026-01-30
YESHAYA SHARON
Chief Financial Officer
$2.94M
@ $185.77 · 2026-01-20
SMITH CHARLES AUBREY III
Officer
$1.55M
@ $182.08 · 2026-01-20
GROSSMAN ERIC F
Officer
$3.97M
@ $184.00 · 2026-01-20
CRAWLEY MANDELL L.
Officer
$1.44M
@ $183.45 · 2026-01-20
PIZZI MICHAEL A
Officer
$3.69M
@ $184.55 · 2026-01-20
SAPERSTEIN ANDREW MICHAEL
President
$5.57M
@ $183.62 · 2026-01-20
PICK EDWARD N.
Chief Executive Officer
$16.43M
@ $164.34 · 2025-10-31
SMITH CHARLES AUBREY III
Officer
$2.81M
@ $140.30 · 2025-07-17
GROSSMAN ERIC F
Officer
$1.69M
@ $141.12 · 2025-07-17
SIMKOWITZ DANIEL A
President
$4.09M
@ $141.13 · 2025-07-17
PIZZI MICHAEL A
Officer
$2.53M
@ $140.62 · 2025-07-17
SIMKOWITZ DANIEL A
President
$3.70M
@ $127.37 · 2025-05-12
HERZ ROBERT H
Director
$95,459
@ $119.32 · 2025-05-02
SAPERSTEIN ANDREW MICHAEL
President
$4.80M
@ $120.00 · 2025-05-02
GROSSMAN ERIC F
Officer
$1.12M
@ $111.65 · 2025-04-15
CRAWLEY MANDELL L.
Officer
$1.15M
@ $138.06 · 2025-01-22
GROSSMAN ERIC F
Officer
$1.78M
@ $136.20 · 2025-01-21
SIMKOWITZ DANIEL A
President
$5.00M
@ $136.61 · 2025-01-21
AKRAM RAJA
Chief Financial Officer
$2.38M
@ $136.01 · 2025-01-21
PIZZI MICHAEL A
Officer
$2.52M
@ $136.92 · 2025-01-21
SAPERSTEIN ANDREW MICHAEL
President
$4.20M
@ $136.43 · 2025-01-21
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
DOC
FearGreed
😐Neutral(50/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
MS
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
DOC
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (50)
MS
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
View DOC Full AnalysisView MS Full Analysis

Frequently Asked Questions: DOC vs MS

Is Healthpeak Properties, Inc. or Morgan Stanley more undervalued in 2026?▼

Based on our discounted cash flow model, MS trades at a 41.3% margin of safety (intrinsic value $314 vs. price $184), compared to DOC's -100.0% margin of safety (intrinsic $0 vs. $19).

Which stock has a wider economic moat, Healthpeak Properties, Inc. or Morgan Stanley?▼

MS scores 80/100 (Wide moat), while DOC scores 57/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Morgan Stanley in financial distress?▼

MS's Altman Z-Score of 0.3 places it in the Distress zone, signaling elevated bankruptcy risk. DOC scores 0.8 (Distress zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Healthpeak Properties, Inc. or Morgan Stanley?▼

MS earns 3.5% ROIC versus DOC's 1.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Healthpeak Properties, Inc.'s or Morgan Stanley's?▼

MS's dividend earns a safety score of 79/100 (Safe), compared to DOC's 33/100 (Unsafe). MS has raised its dividend for 3 consecutive years.